Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.34 USD | -1.22% | -10.32% | -27.90% |
Business Summary
Number of employees: 6,550
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Screening
74.6
%
| 1,425 | 68.4 % | 1,865 | 74.6 % | +30.88% |
Precision Oncology
25.2
%
| 601 | 28.9 % | 629 | 25.2 % | +4.59% |
COVID-19 Testing
0.2
%
| 58 | 2.8 % | 6 | 0.2 % | -89.75% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
93.9
%
| 1,967 | 94.4 % | 2,346 | 93.9 % | +19.32% |
Non-United States
6.1
%
| 118 | 5.6 % | 153 | 6.1 % | +30.18% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-05 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-01-31 |
Chief Tech/Sci/R&D Officer | - | 18-12-31 | |
Tomasz Beer
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
D. Coward
BRD | Director/Board Member | 59 | 14-12-31 |
Kristen Weiler
SAM | Sales & Marketing | - | 17-12-31 |
Ana Hooker
PRN | Corporate Officer/Principal | 58 | 12-12-31 |
Kyle Stacey
AUD | Comptroller/Controller/Auditor | - | 08-12-31 |
James Herriott
LAW | General Counsel | 44 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 14-12-31 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 20-04-21 |
Timothy Scannell
BRD | Director/Board Member | 59 | 23-10-30 |
Daniel Levangie
BRD | Director/Board Member | 73 | 10-07-15 |
Director/Board Member | 69 | 09-04-23 | |
Paul Clancy
BRD | Director/Board Member | 62 | 21-03-17 |
Pierre Jacquet
BRD | Director/Board Member | 57 | 19-07-24 |
James Doyle
BRD | Director/Board Member | 78 | 14-07-23 |
Director/Board Member | 75 | 19-03-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 184,529,721 | 182,722,621 ( 99.02 %) | 0 | 99.02 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Medical Specialties
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.90% | 9.84B | |
-4.81% | 3.15B | |
+31.37% | 2.99B | |
-14.73% | 2.15B | |
-14.39% | 1.8B | |
+70.99% | 1.49B | |
+23.17% | 770M | |
-2.18% | 762M | |
+3.18% | 308M | |
+6.63% | 210M |
- Stock Market
- Equities
- EXAS Stock
- Company Exact Sciences Corporation